Alzheimer’s Breakthrough Reduces Memory Loss in 7 Out Of 8

Medical News Today – An open-label clinical trial working with eight people with Alzheimer’s disease concluded that a new wearable device that emits electromagnetic impulses was able to significantly improve memory loss in seven of these participants within 2 months.

An innovative wearable device can significantly reduce memory loss in Alzheimer’s disease, according to a new clinical trial.

Alzheimer’s disease affects millions of people in the United States and worldwide, but as yet there is no cure for this progressive neurodegenerative condition.

The condition’s main physiological characteristic is the aggregation of beta-amyloid and tau protein in the brain, which disrupt normal communication pathways between brain cells.

Scientists have been aware of this aspect of Alzheimer’s for years but have so far been unable to prevent the aggregates from forming, or to dissolve them once formed — not in humans, at least.

But now, researchers affiliated with NeuroEM Therapeutics — a medical device company based in Phoenix, AZ — have developed a wearable device that, according to their recent open-label clinical trial, can significantly reduce memory loss in Alzheimer’s by disaggregating toxic protein formed in the brain.

The device has the shape of a cap, and it emits electromagnetic waves in a frequency that, as preclinical studies in mice have shown, can help reverse memory loss.

The research team that conducted the clinical trial reports the groundbreaking results in a study paper that appears in the Journal of Alzheimer’s Disease.

“Despite significant efforts for nearly 20 years, stopping or reversing memory impairment in people with Alzheimer’s disease has eluded researchers,” notes one of the researchers, Dr. Amanda Smith, who is the director of clinical research at the University of South Florida Health’s Byrd Alzheimer’s Institute in Tampa. Read more. 

RECENTLY: 

Mayo Clinic’s Top 3 Anti-Alzheimer’s Tips | VIDEO

Yet Another FDA-Approved Drug Linked To Alzheimer’s